Profile: Conrex Pharmaceutical Corp develops Permeation Enhancement Technology™ (PET). Our PET enables the temporary transport of drug molecules & hormones into and through the skin. Diclofenac acid is a non steroidal anti-inflammatory drug used in the evaluation of in-vitro percutaneous (skin) permeation. We also supply Franz cell apparatus, which is used for in-vitro studies to measure the enhanced percutaneous permeation of drugs & nutrient molecules formulated with PET.